 |
| Contact Us |
|
| sanofi-aventis (Malaysia) Sdn Bhd |
8th Floor, PNB Damansara
No. 19 Lorong Dungun
Damansara Heights
50490 KUALA LUMPUR
Malaysia
Tel: + (603) 2089 3333
Fax: + (603) 2089 3389
|
| Contact us |
|
|
|
|
 | Your Health |
|
|
In our market, the principal area of business of sanofi-aventis is ethical pharmaceuticals. Our core therapeutic areas are cardiovascular disease and thrombosis; diseases of the central nervous system; oncology; internal medicine; and metabolic disorders.
|
|
|
|
| Central Nervous System |
|
|
Central nervous system diseases especially in neurology and psychiatry have had more drugs developed in the last ten years than in a whole century of research.
|
|
| Internal Medicine |
|
|
Internal medicine is the practice of preventing and treating general diseases. sanofi-aventis’ internal medicine portfolio includes for a wide range of general medical conditions such as, benign prostatic hyperplasia, osteoporosis and rheumatoid arthritis.
|
|
| Metabolic Disorders |
|
|
Diabetes mellitus (DM) is the most common metabolic condition affecting the world population. Malaysia is the country with the highest prevalence of DM in the South East Asia region .
|
|
| Cardiovascular |
|
|
1,000,000,000 adults across the globe suffer from cardiovascular diseases and the figures are rising. Cardiovascular diseases have become the leading cause of mortality in both the developed and the developing world.
|
|
| Oncology |
|
|
Cancer is a disease of the cell. It develops when cells in a part of the body begin to grow out of control.
|
|
| Thrombosis |
|
|
Thrombosis affects both the arterial (Atherothrombosis) and venous (Venous Thromboembolism) systems.
|
|
| Vaccines |
|
|
Immunization or vaccination consists of introducing into the body of a healthy person a very small quantity of inactivated or weakened microbes of the disease against which protection is to be conferred. These microbes teach the body to defend itself and thereby immunize it against the disease.
|
|
|
 |
|
Corporate Information
Get more information about sanofi-aventis’ activities
|
|
|
 |
|
